Among ECM mediators, cytokine transforming growth factor-beta 1 (TGF-β1) has been historically identified as a master regulator of the disease process in SSc since it accelerates fibrosis in the skin by inducing collagen production (2, 3). This evidence concerns the gene TGFB1 and systemic sclerosis.